<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of myeloid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> diagnosed mostly in elderly persons, are of increasing interest in an aging population and are associated with variable risk of progression to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The numbers of <z:hpo ids='HP_0011420'>deaths</z:hpo> related to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in the population are underestimated in routine US <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality statistics which are based on only the underlying cause (UC) rather than multiple causes (MCs) of <z:hpo ids='HP_0011420'>death</z:hpo> recorded on <z:hpo ids='HP_0011420'>death</z:hpo> certificates </plain></SENT>
<SENT sid="2" pm="."><plain>Additional <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-related <z:hpo ids='HP_0011420'>deaths</z:hpo>, however, may be missed if some <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients die with mention of <z:hpo ids='HP_0001909'>leukemia</z:hpo> but not <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> on their <z:hpo ids='HP_0011420'>death</z:hpo> certificate </plain></SENT>
<SENT sid="3" pm="."><plain>This requires studies of MCs of <z:hpo ids='HP_0011420'>death</z:hpo> among <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients in population-based <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> registries </plain></SENT>
<SENT sid="4" pm="."><plain>This study examined MCs of <z:hpo ids='HP_0011420'>death</z:hpo> among patients diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in 2001- 2009 and reported to the population-based Connecticut <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> Registry </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> was the UC for 199 <z:hpo ids='HP_0011420'>deaths</z:hpo> (25.7% of <z:hpo ids='HP_0000001'>all</z:hpo> 773) and was coded as other than UC for 160 (20.7%) </plain></SENT>
<SENT sid="6" pm="."><plain>Another 121 (15.7%) <z:hpo ids='HP_0011420'>death</z:hpo> records, however, had <z:hpo ids='HP_0001909'>leukemia</z:hpo> without mention of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>; the majority were coded to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and most of the others as unspecified type of <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>If these 121 <z:hpo ids='HP_0011420'>deaths</z:hpo> are added to the 359 with mention of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, the total of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-related <z:hpo ids='HP_0011420'>deaths</z:hpo> would be 480 (or 62.1% of <z:hpo ids='HP_0000001'>all</z:hpo> 773 <z:hpo ids='HP_0011420'>deaths</z:hpo>) </plain></SENT>
<SENT sid="8" pm="."><plain>A total of 178 <z:hpo ids='HP_0011420'>deaths</z:hpo> (23.0% of <z:hpo ids='HP_0000001'>all</z:hpo> 773) were coded to <z:hpo ids='HP_0001909'>leukemia</z:hpo> as the UC, and would be included with <z:hpo ids='HP_0001909'>leukemia</z:hpo> (not <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) in routine <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality statistics </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0001909'>Leukemia</z:hpo> diagnosed since 2010 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients is reportable to registries as a new primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>This new rule will help central <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registries to confirm <z:hpo ids='HP_0001909'>leukemia</z:hpo> diagnoses coded on <z:hpo ids='HP_0011420'>death</z:hpo> records, as part of the process of improving surveillance of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality rates in the population </plain></SENT>
</text></document>